Our purpose:
Better health
through adherence.

Our mission

When someone is prescribed medication what matters most is that they take it as intended so they can receive the full benefit. The reality is once they leave the doctor’s office, we don’t know what they’re going to do next. Or how to help them best.

AdhereTech delivers solutions that make it easy for all patients to establish and maintain positive medication-taking behaviors leading to better health. It’s the in-home partner every medication should have. An elegantly simple and proven system designed to gently remind people to take their medications and intervene when they don’t — early enough to make a difference. Making sure not a day is lost on their path to better health.

Because every dose — and every day — counts.

Here's how we do it

To help us consistently deliver these results, we hold ourselves to 2 key principles that drive every decision we make:

1

Making adherence effortless

Patients with a serious disease already have enough to deal with. AdhereTech recognizes that it is critical to work with the patient to make adherence effortless, without adding to their burden.

Aidia doesn’t require any patient setup, as each smart device is delivered pre-set to the patient’s personal dosing schedule. The patient just has to activate the device and the system will begin operating via an always-on cellular signal.

By seamlessly integrating into a patient’s life, with gentle reminders and personalized support, Aidia gradually enables positive behavior change over time. Our centralized database and proprietary algorithms prompt intervention only when a patient starts to become non-adherent. These timely interventions escalate as needed, to ensuring that patients have the opportunity to get back on track to better health.

2

Ensuring patient safety & privacy

Because patient safety and privacy is essential to the way we do business, we ensure full compliance with all necessary legal and regulatory requirements and safety standards (including but not limited to: FDA, HIPAA, TCPA, CE, USP, ISO, FCC, and more).

TED Talk: Why understanding patients is important to adherence

Achieving medication adherence must go beyond the use of a smart device. In this 5-minute TED Talk, AdhereTech Co-Founder Josh Stein discusses the top 3 principles that guided the AdhereTech approach to patient-centric design.

Get to know the team

Innes Meldrum
Innes Meldrum
Chief Executive Officer

Overall Career Driver: Championing disruptive change to broadly impact patient health outcomes through collaborative and purpose-driven leadership.

Innes Meldrum
Chief Executive Officer

With 30 years of leadership experience in both technology and pharmaceuticals, Innes Meldrum brings an authentic, charismatic, cross-cultural leadership approach to successfully deliver business growth through highly engaged organizations.

Innes comes to AdhereTech from the Clinical Biotech space and prior to that was the CCO for Otsuka North America where he had responsibility for all commercial aspects of Otsuka's multi-billion dollar pharma portfolio.

With broad experience both globally and locally, at large and small companies in the Pharma space (Novartis, Orexo, Otsuka and Reset) and prior to this within the Technology space (Nortel, HP and Agilent Technologies), Innes has a background ideally suited to leading Adheretech.

He has a BEng in Electrical and Electronic engineering from the University of Strathclyde in Scotland.

Innes enjoys working out, reading, golfing, has a qualification in Single Malt Scotch and loves Karaoke and Haggis.

Jeremy Gilbert
Jeremy Gilbert
Chief Product Development Officer

Overall Career Driver: Leading teams that create and bring to market cutting-edge medical technologies that will help people live longer, healthier lives.

Jeremy Gilbert
Chief Product Development Officer

Jeremy Gilbert is Chief Product Development Officer for AdhereTech. He joined the company in 2021, bringing extensive leadership expertise spanning the healthcare industry. At AdhereTech, Jeremy leads the teams that drive the lifecycle of new products including conception, design, technical development, go-to-market strategy, and launch.

Jeremy previously drove product and technology for health technology companies in his roles as Chief Product Officer for Pear Therapeutics and as Vice President of Product and Strategy for PatientsLikeMe.

Jeremy holds a BA in Computer Science from Brandeis University, as well as an MBA from the MIT Sloan School of Management.

Ramy Elsisi
Ramy Elsisi
Chief Financial Officer

Overall Career Driver: Transforming financial and operational results to maximize enterprise and shareholder value.

Ramy Elsisi
Chief Financial Officer

Ramy brings more than 20 years of experience as a strategic finance executive, enterprise leader, and operational business partner in the pharmaceutical and consumer health industries. Most recently he was the Head of Commercial Finance at Otsuka Pharmaceuticals North America.

Previously, he held numerous senior positions of increasing responsibility over 15 years at Merck, Schering Plough and Bayer serving as CFO of Latin America, Canada and Western Europe, Global Head of Upper Respiratory /Allergy and Cough & Cold business units, and Head of Global R&D and strategic planning.

Prior to that, he led the Financial Planning & Analysis groups at Johnson & Johnson, and Mercedes-Benz USA.

In addition, Ramy’s advisory experience spans a wide range of projects for start-up, public, and private companies in the life sciences and consumer health industries.

Ramy holds an MBA in Finance and International Business, and a BS in Finance and Accounting from Ramapo College of NJ.

Whitney Salamone
Whitney Salamone
Vice President of Commercial Operations

Overall Career Driver: Leveraging innovative and digital health solutions to enact positive behavior change in at-risk populations.

Whitney Salamone
Vice President of Commercial Operations

Currently serving as the Vice President of Commercial Operations at AdhereTech, Whitney plays a pivotal role in shaping the company's commercial strategy. Her primary focus is on implementing successful solutions for medication adherence in partnering organizations. Whitney's dedication and expertise position her as a key player in AdhereTech's commitment to improving medication adherence through cutting-edge solutions.

Previously, Whitney's work was focused in the mental health and addiction treatment sectors, with a diverse background that showcases her expertise. At Advocates for Human Potential, she played a vital role as a member of SAMHSA’s Behavioral Health HIV/AIDS Technical Assistance Center, providing technical assistance in substance abuse prevention with a focus on HIV/AIDS and Hepatitis C. Transitioning into the digital health space, Whitney contributed significantly to Headspace for Organizations | Formerly Headspace Health and Ginger, now part of Headspace Health, as an original health coach and platform contributor for mental health guidance. Her journey continued at American Addiction Centers, where she excelled as a Reputation Management Specialist, overseeing internal and external reputation efforts and leading review acquisition strategies.

Whitney holds a master’s degree in public health from Boston University along with a BA from SUNY Geneseo in psychology.

John Langhauser
John Langhauser
Co-Founder, Chief Operating Officer and Chief Information Security Officer

Overall Career Driver: Building easy-to-use technology that connects patients to high quality care.

John Langhauser
Co-Founder, Chief Operating Officer and Chief Information Security Officer

John Langhauser is the technical cofounder and former Chief Technology Officer at AdhereTech. In his current role as Chief Operating Officer, he partners with senior leaders to ensure that the patient-first, customer-first ideals AdhereTech was founded upon continue to be reflected in every product launch, patient interaction and customer experience.

As cofounder, John was directly responsible for early software and product development, strategic product roadmapping and corporate governance. Throughout the growth of AdhereTech, he has focused on product development, process improvement, and quality control. Prior to cofounding AdhereTech in 2012 John was a software engineer at Bridgewater Associates.

John holds an MS in Computer Science and a BS in Electrical Engineering and Computer Science from Yale.

AdhereTech Board Members

Neale Trangucci
Neale Trangucci
Chair of the Board

Neale Trangucci retired in 2014 after 33 years on Wall Street in a variety of roles focused on investing in financially distressed companies. Mr. Trangucci is currently a member of the boards of directors of AdhereTech and Currax Pharmaceuticals. He earned a master’s degree in International Affairs from Columbia University and a bachelor of science degree from Bucknell University.

Dan Raynor
Dan Raynor
Argentum Private Equity

Dan Raynor is Managing Partner and co-founder of The Argentum Group, a New York-based growth equity firm that helps scale bootstrapped B2B software, technology-enabled, and business services companies. Mr. Raynor received a B.S. in economics from The Wharton School, University of Pennsylvania.

Elliot Zeelander
Elliot Zeelander
Mathers Private Equity

Elliot Zeelander has more than 30 years of investment management experience. Mr. Zeelander has been the sole General Partner and Managing Director of Mathers Associates since 2014. Today, Mathers manages $100 million, invests in public equity, primary and tertiary private equity, and has over 20 direct co-investments representing 50% of its assets. Mr. Zeelander sits on the boards of AdhereTech, Conner Industries, and EdgeIQ.

Paul Sekhri
Paul Sekhri
Independent Director and CEO of vTv Therapeutics

Mr. Sekhri has over 35 years of experience in the Life Science Industry. His experience encompasses senior management in large corporate pharmaceutical and biotechnology companies, as well as private equity and venture capital. Mr. Sekhri has been a Director on more than 35 private, public company, and non-profit Boards and is currently a member of the Board of Directors of eGenesis, Inc., Spring Discovery, and Veeva Systems Inc.

Josh Stein
Josh Stein
AdhereTech Co-Founder

Josh Stein cofounded AdhereTech in 2011, providing the vision and business acumen to turn an idea into a thriving healthcare technology business that improves patients’ lives, and spans the complex markets of healthcare, software, enterprise sales, hardware IoT, data analysis and clinical research. Mr. Stein earned his MBA from the Wharton School of Business and a BA from Washington University in St. Louis.

John Langhauser
John Langhauser
AdhereTech Co-Founder

John Langhauser is the technical co-founder and former Chief Technology Officer at AdhereTech. Prior to cofounding AdhereTech in 2012, he was a software engineer at Bridgewater Associates. Mr. Langhauser holds an MS in Computer Science and a BS in Electrical Engineering and Computer Science from Yale.

Innes Meldrum
Innes Meldrum
AdhereTech CEO

With 30 years of leadership experience in both technology and pharmaceuticals, Innes Meldrum brings an authentic, charismatic, cross-cultural leadership approach to successfully deliver business growth through highly engaged organizations. Mr. Meldrum has a BEng in Electrical and Electronic engineering form the University of Strathclyde in Scotland.

Interested in joining our growing team?

View job openings